---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-357258"
form_type: "8-K"
ticker: "CALC"
cik: "0001534133"
company_name: "CalciMedica, Inc."
filed_at: "2026-08-19T22:36:37+00:00"
generated_at: "2026-08-20T10:05:45.873376+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CalciMedica stockholders approve reverse split, 7.5M-share plan increase, warrant issuances

## Summary
- Approved reverse stock split at ratio between 1-for-2 and 1-for-10, with corresponding reduction in authorized shares; board to set timing and ratio.
- Equity plan amended to increase shares by 7,500,000; annual auto reserve now includes shares from convertible preferred and pre-funded warrants.
- Elected Allan Shaw and Robert N. Wilson as Class III directors for three-year terms.
- Approved issuance of up to 18,673,429 shares under Series A/B warrants (Rule 5635(d)) and 1,680,565 each for officers/directors (Rule 5635(c)).
- Say-on-pay advisory vote passed; frequency of one year, with next vote no later than 2032 annual meeting.

## SEC filing metadata
- accession: 0001193125-26-357258
- form_type: 8-K
- ticker: CALC
- cik: 0001534133
- company_name: CalciMedica, Inc.
- filed_at: 2026-08-19T22:36:37+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534133/000119312526357258/0001193125-26-357258-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534133/000119312526357258/d434771d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-357258
- JSON: https://secwatch.observer/filing/0001193125-26-357258.json
- Plain text: https://secwatch.observer/filing/0001193125-26-357258.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.